Inactive Instrument

Highlights Tyme Technologies, Inc.

Equities

TYME

US90238J1034

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Syros Pharmaceuticals Closes Tyme Technologies Merger, Private Placement	22-09-16	MT
Syros Pharmaceuticals, Inc. completed the acquisition of Tyme Technologies, Inc. from a group of shareholders.	22-09-15	CI
Syros Pharmaceuticals, Tyme Technologies Shares Surging in Late Trade After Shareholder Merger Nod	22-09-15	MT
TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote “FOR” Proposed Merger of Syros and Tyme	22-09-07	AQ
Tyme Technologies, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-09	CI
Syros Pharmaceuticals to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement	22-07-06	AQ
Syros Pharmaceuticals to Acquire Tyme Technologies in All-Stock Deal	22-07-05	MT
Tyme Technologies : Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement - Form 8-K	22-07-05	PU
Earnings Flash (TYME) TYME TECHNOLOGIES Posts 2022 Loss of $-0.14	22-05-25	MT
Tyme Technologies, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-25	CI
Tyme Technologies to Explore Strategic Options; Shares Rise Pre-Bell	22-03-29	MT
TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research Annual Meeting 2022	22-03-09	CI
Tyme Technologies Narrows Fiscal Q3 Loss	22-02-11	MT
Tyme Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-11	CI
Tyme Technologies, Inc. Provides Update on Precision Promise Trial in Metastatic Pancreatic Cancer	22-01-26	CI
Tyme Technologies Hit With Potential Delisting Notice After Stock Price Drops Under $1 Per Share	21-12-29	MT
Tyme Technologies, Inc. Announces Additional Encouraging Preclinical Data on the Effect of TYME-19 in SARS CoV-2 Infections	21-12-14	CI
Earnings Flash (TYME) TYME TECHNOLOGIES Reports Q2 Loss $-0.03	21-11-08	MT
Tyme Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-08	CI
TYME Technologies, Inc. Announces First Patient Dosed in Phase II OASIS Trial Evaluating the Potential Benefits of Oral SM-88 for Patients with Metastatic HR+/HER2- Breast Cancer After Treatment with a CDK4/6 Inhibitor	21-09-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Tyme Technologies, Inc.

Equities

TYME

US90238J1034

Highlights

Filters